The first love, you never forget. The last heart valve, you might remember better than the first

Key Points Valve‐in‐valve (VIV) transcatheter aortic valve replacement (TAVR) does not increase cerebrovascular risk compared with TAVR in native aortic valves; the only predictors of new brain lesions were age and postdilatation. Wise choice of the biological valve at the time of surgical aortic re...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2020-04, Vol.95 (5), p.1022-1023
Main Authors: Aranzulla, Tiziana Claudia, Musumeci, Giuseppe
Format: Article
Language:English
Subjects:
Aortic valve
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Key Points Valve‐in‐valve (VIV) transcatheter aortic valve replacement (TAVR) does not increase cerebrovascular risk compared with TAVR in native aortic valves; the only predictors of new brain lesions were age and postdilatation. Wise choice of the biological valve at the time of surgical aortic replacement, routine use of cerebral protection devices, and new therapeutic paths may be important. Larger studies are needed, hopefully with systematic postdilatation or bioprosthetic valve fracture in cases of residual high transvalvular gradients after VIV TAVR.
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.28873